Form 4: Calumet EVP Scott Obermeier Awarded Equity
Insider Transaction Disclosure (Form 4)
Calumet, Inc. EVP of Specialties, Scott Obermeier, was granted 17,392 Restricted Stock Units as part of his compensation.
Summary
- Scott Obermeier, Executive Vice President of Specialties at Calumet, Inc. (CLMT), was granted a total of 17,392 Restricted Stock Units (RSUs).
- The transaction date for these grants was February 24, 2026.
- One grant consisted of 9,654 performance-based RSUs for 2025, certified by the Company's Board of Directors on the transaction date, subject to service-based vesting through February 25, 2028.
- A second grant involved 7,738 RSUs that will vest on February 24, 2029.
- Each RSU is economically equivalent to one share of Calumet, Inc. common stock, par value $0.01 per share.
- The acquisition price for these RSUs was $0.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive disclosure, reflecting a routine executive compensation event that aligns management incentives with shareholder value without indicating any immediate operational or financial changes.
Positives
- The grant of Restricted Stock Units aligns executive interests with shareholder value, as the value of the RSUs is tied to the company's common stock performance.
- The performance-based nature of 9,654 RSUs indicates a focus on achieving specific company objectives for 2025.
Future Outlook
The filing indicates future vesting events for the granted Restricted Stock Units, with service-based vesting for 9,654 units extending through February 25, 2028, and the remaining 7,738 units vesting on February 24, 2029.
Industry Context
StockSavvy.ai notes that the grant of Restricted Stock Units to key executives is a common practice in the industry, serving as a form of long-term incentive compensation designed to align management's interests with those of shareholders and encourage retention.
Comparison to Industry Standards
- Equity grants, particularly Restricted Stock Units with performance and service-based vesting, are a standard component of executive compensation packages across various industries, including energy and specialty chemicals, similar to practices seen at companies like Valvoline Inc. or HollyFrontier Corporation.
- The structure of these grants, combining performance and time-based vesting, is consistent with best practices aimed at motivating executives to achieve strategic goals and ensure long-term commitment.
Related Party Transactions
- Grant of Restricted Stock Units to Scott Obermeier, an Executive Vice President, which is a transaction between the company and a related party as part of his compensation package.
Stakeholder Impact
- Shareholders: The equity grant aims to align the interests of EVP Scott Obermeier with those of shareholders, potentially leading to improved long-term company performance.
- Employees: This filing specifically pertains to executive compensation and does not directly impact the broader employee base, though it reflects the company's compensation philosophy for key personnel.
Next Steps
- The 9,654 performance-based Restricted Stock Units will continue to be subject to service-based vesting requirements through February 25, 2028.
- The 7,738 Restricted Stock Units are scheduled to vest on February 24, 2029.
Key Dates
| Date | Description |
|---|---|
| 02/24/2026 | Transaction date for the grant of 9,654 performance-based Restricted Stock Units (RSUs) and 7,738 service-based RSUs. Also, the date 2025 performance for the 9,654 RSUs was certified by the Board of Directors. |
| 02/26/2026 | Date the Form 4 was signed by Connor J. Egan, as attorney-in-fact for Scott Obermeier. |
| 02/25/2028 | End date for service-based vesting requirements for the 9,654 performance-based Restricted Stock Units. |
| 02/24/2029 | Vesting date for the 7,738 Restricted Stock Units. |
Recommendation
holdThis Form 4 reports a routine equity grant to an executive, which is a standard component of compensation and does not provide new information to alter an investment thesis. It is a disclosure of an incentive, not a signal of immediate operational or financial performance changes that would warrant a change in recommendation.
Keywords
Calumet, CLMT, Form 4, Insider Transaction, Restricted Stock Units, Executive Compensation, Equity Grant, Scott Obermeier
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.